Seegene unveils world's first commercialized '3 Ct' PCR assay
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SEOUL, South Korea, April 26, 2022 /PRNewswire-AsiaNet/ -- -Provides Ct value of three targets in one channel; '3 Ct' PCR assay to launch in H1-"Dream MDx technology" developed based on Seegene's 20-year expertise; combines 19 different patented technologies, including DPO(TM), TOCE(TM), MuDT(TM)-'3 Ct'...
Authors: LATEST ASIANET NEWS RELEASES